Trevi Therapeutics, Inc. (TRVI) Presents at Morgan Stanley 23rd Annual Global Healthcare

Question-and-Answer SessionMaybe we could just start with an overview of the company for those who might be less familiar, or newer to the story? That would be great.Jennifer GoodCo-Founder, CEO, President, Interim Principal Financial Officer & Director Yes, happy to do that. And thank you to everyone that came. I see some old friends in the audience. And Judah, thank you to you and Morgan Stanley, our newest relationship, newest analyst. That's great. So Trevi has had a strong year. We are a single-asset c ...